Yu. V. Burenkov

Yu. V. Burenkov

Auto-generated profile, based on publicly available information

Yu. V. Burenkov

Burdenko Voronezh State Medical University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
YBYu. V. Burenkov
Yu. V. Burenkov
VSV. I. Shevtsova
V. I. Shevtsova
OKO. N. Krasnorutskaya
O. N. Krasnorutskaya
YKYu. A. Kotova
Yu. A. Kotova
Over the past 50 years, the number of obese people has increased many times. Despite the excess weight, many patients may be metabolically healthy. But studies show that this condition is an intermediate stage ending with a metabolically unhealthy phenotype, which is associated with an increase in the incidence of cardiovascular events. The concept of metabolically unhealthy obesity is characterized by altered levels of various biomarkers, the significance of which in the context of predicting a metabolically unhealthy phenotype remains to be studied. The review is devoted to the analysis of modern research data on the role of hyperuricemia, gut microbiota and its metabolites, adipocytokines, as well as an assessment of their relationship with a metabolically unhealthy obesity.

22 April 2026 in Russian Journal of Cardiology
Verified
Journal Article
Closed access
YBYu. V. Burenkov
Yu. V. Burenkov
VSV. I. Shevcova
V. I. Shevcova
DKD. E. Kutilova
D. E. Kutilova
ATA. O. Tarasova
A. O. Tarasova
Aim . To assess performance and methodological quality of machine learning (ML) models for predicting outcomes in patients with heart failure with preserved (HFpEF) and reduced (HFrEF) ejection fraction. Material and methods. A systematic search of original publications in PubMed and eLibrary (2015-2025) was conducted. Twenty studies were included in the review. Methodological quality was assessed using PROBAST. R e sults . The performance of the ML models was comparable for HFpEF and HFrEF (median AUC, 0,812 in both groups, p=0,48). The analysis showed that 70% of the studies were at high risk of bias, primarily due to the lack of external validation. The clustering models demonstrated clinically meaningful stratification, identifying phenotypes with significantly increased risk (e.g., hazard ratio 2,99 (95% confidence interval 2,41-3,7, p<0,001)). Conclusion . ML models demonstrate moderate-to-high performance. However, the lack of external validation limits their readiness for clinical application. Standardization of methodology for future studies and prospective validation are needed.

20 March 2025 in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
Verified
Journal Article
Open access
PDF file
VSV. I. Shevtsova
V. I. Shevtsova
APA. A. Pashkova
A. A. Pashkova
ASA. N. Shevtsov
A. N. Shevtsov
YBYu. V. Burenkov
Yu. V. Burenkov
The aim of the study: to divide a heterogeneous group of patients with chronic heart failure, taking into account the parameters of body composition and severity of painful symptoms. Object and methods. The study involved 298 patients with CHF. The body composition was assessed: the presence of sarcopenia and obesity (with the calculation of the muscle mass index), functional class, left ventricular ejection fraction, markers galectin-3, hsCRP sodium uretic peptide, Bartel index. A 10-point Edmont scale was used to assess the severity of painful symptoms. A two-stage cluster analysis was performed. Results. Three clusters were identified in the patient structure: the share of the first in the overall structure was 23.2%, the second – 61.1%, the third – 15.8%. It was determined that the first cluster includes patients with sarcopenic obesity. They are characterized by the maximum galectin level and ejection fraction in the sample. They have low walking speed, dynamometry, NТ-proBNP. The intermediate position is occupied by patients of the second cluster (patients with isolated body composition disorder or without it). They are characterized by high walking speed, dynamometry indicators, 6-minute walking test value, Barthel index. Patients of the third cluster are people with low body weight and sarcopenia. They have the maximum Sarcopenia Fast questionnaire level with low walking speed, T6W value, dynamometry indicators and significantly reduced ejection fractions and a high NТ-proBNP level. Patients of the first cluster have the most pronounced pain and fatigue with the lowest level of depression. In patients of the second cluster, pain, fatigue, drowsiness, nausea, shortness of breath, anxiety, and well-being are expressed much less than in patients of the other clusters. And patients of the third group have the highest level of drowsiness, nausea, appetite disorders, shortness of breath, depression, anxiety, and deterioration of well-being. Conclusions. The structure and severity of distressing symptoms varies depending on the cluster and, accordingly, the patient's body composition, which can be used in constructing algorithms for providing palliative care to patients with CHF.

13 June 2026 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Closed access
YBYu. V. Burenkov
Yu. V. Burenkov
VSV. I. Shevcova
V. I. Shevcova
AAA. D. Akhyadov
A. D. Akhyadov
IAI. P. Alferova
I. P. Alferova
The review aim was to develop a machine learning (ML) algorithm adapted to Russian conditions for creating reproducible prediction models of heart failure (HF) course, based on an analysis of international methodological quality standards and a review of existing practices. To this end, the international standards Prediction Model Risk Of Bias Assessment Tool (PROBAST) and Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis Or Diagnosis — Machine Learning (TRIPOD-ML) were systematized. An extensive search and methodological assessment of Russian studies from 2016-2025, where machine learning was used in patients with HF, were also conducted. The analysis revealed a critical shortage of Russian studies devoted to predicting the HF course. A review of existing studies revealed the following systemic deficiencies: no external validation, data leakage at the feature selection stage, incomplete reporting, and neglect of clinical utility assessment. The causes of these problems are systemic and related to data fragmentation, interdisciplinary gaps, and regulatory gaps. The gap between international standards and Russian practice is not due to technological lag, but to a lack of methodological culture. A step-by-step, practical algorithm is proposed as a solution, focusing on strict data separation, comprehensive validation, transparent reporting, and clinical utility assessment. Implementation of this algorithm will be an important step in the development of evidence-based predictive modeling for HF in Russia.